Search Results

Valuing Treatment With Infliximab for Ankylosing Spondylitis Using a Willingness-to-Pay Approach.

• Authors : Webers C; Maastricht University Medical Center and School for Public Health and Primary Care (CAPHRI), Maastricht University, Maastricht, The Netherlands.; Essers I

Subjects: Drug Costs* ; Health Expenditures* ; Patient Acceptance of Health Care*

• Source: Arthritis care & research [Arthritis Care Res (Hoboken)] 2018 Apr; Vol. 70 (4), pp. 608-616. Date of Electronic Publication: 2018 Feb 18.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101518086 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Health-related quality-of-life improvements during 98 weeks of infliximab therapy in patients with plaque-type psoriasis in real-world practice.

• Authors : Shear, N.; Hartmann, M.; Toledo-Bahena, M.

Subjects: PSORIASIS; INFLIXIMAB; HEALTH status indicators

• Source: Quality of Life Research. Aug2016, Vol. 25 Issue 8, p2031-2040. 10p. 4 Charts, 2 Graphs.

Record details

Editorial: antigenic response to CT‐P13 and infliximab originator in IBD shows similar epitope recognition—evidence from basic science supports safe switching to biosimilars.

• Authors : Pouillon, L.^1,2; Allocca, M.³; Peyrin‐Biroulet, L.¹

Subjects: *EPITOPES; *INFLIXIMAB; *INFLAMMATORY bowel diseases

• Source: Alimentary Pharmacology & Therapeutics. Sep2018, Vol. 48 Issue 5, p574-575. 2p.

Record details

Juvenile generalized pustular psoriasis with IL36RN mutation treated with short-term infliximab.

• Authors : Pan, Junwei¹; Qiu, Li¹; Xiao, Ting¹

Subjects: *INFLIXIMAB; *PSORIASIS; *METHYLPREDNISOLONE

• Source: Dermatologic Therapy. May2016, Vol. 29 Issue 3, p164-167. 4p.

Record details

Prognostic factors for long-term infliximab treatment in Crohn's disease patients: a 20-year single centre experience.

• Authors : Billiet, T.; Cleynen, I.; Ballet, V.

Subjects: INFLIXIMAB; INFLAMMATORY bowel disease treatment; DRUG efficacy

• Source: Alimentary Pharmacology & Therapeutics. Oct2016, Vol. 44 Issue 7, p673-683. 11p. 1 Diagram, 3 Charts, 2 Graphs.

Record details

Letter: comparative safety and efficacy of infliximab vs. adalimumab in Crohn's disease - should one consider disease location? Authors' reply.

• Authors : Narula, N.¹ ; Reinisch, W.^1,2

Subjects: *MEDICATION safety; *INFLIXIMAB; *CROHN'S disease

• Source: Alimentary Pharmacology & Therapeutics. Oct2016, Vol. 44 Issue 7, p772-773. 2p.

Record details

SUCCESSFUL INFLIXIMAB TREATMENT IN COGAN SYNDROME WITH CARDIAC COMPLICATIONS.

• Authors : Gülle, Semih; Güler, Merve Çelik; Gürel, Duygu

Subjects: SUCCESS; RISK assessment; CARDIOVASCULAR diseases

• Source: Rheumatology Quarterly; Mar2024, Vol. 2 Issue 1, p49-50, 2p

Record details

Early drug and anti-infliximab antibody levels for prediction of primary nonresponse to infliximab therapy.

• Authors : Bar‐Yoseph, H.; Levhar, N.; Selinger, L.

Subjects: INFLIXIMAB; MONOCLONAL antibodies; INFLAMMATORY bowel diseases

• Source: Alimentary Pharmacology & Therapeutics. Jan2018, Vol. 47 Issue 2, p212-218. 7p.

Record details

Agricola

Record details

Agricola

Record details